Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials
Palo Alto, CA, January 21, 2022 – The “Database of Biomarkers Curated from Oncology Trials” report has been added to the enlightenbio
Palo Alto, CA, January 21, 2022 – The “Database of Biomarkers Curated from Oncology Trials” report has been added to the enlightenbio
Amgen now has regulatory approval on both sides of the Atlantic for Lumykras, the culmination of many years of effort to bring a drug to market that
Fresh from a sizeable funding round that raised $370 million, artificial intelligence-based drug discovery firm Generate Biomedicines has just signed
Amgen will partner with Generate Biomedicines to discover and create protein therapeutics for five targets across several therapeutic areas and
At its second attempt, Novartis has won FDA approval for its cholesterol lowering drug inclisiran, which can reduce levels with just two injections a
Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers
The FDA has approved AstraZeneca and Amgen’s severe asthma hope tezepelumab, exonerating the drugmakers’ decision to press ahead with a
J.P. Morgan Goes Virtual as Key Companies Back Out Published: Dec 15, 2021 By Gail Dutton BioSpace On Wednesday morning, J.P. Morgan Chase
Injectable antibodies targeting PCSK9 have failed to take off as expected in the cholesterol-lowering market, but Merck & Co hopes to do much
With their extending reaches, resources and influence, pharmaceutical heavyweights have the potential to shape the digital health landscape to line
Amgen and Neumora Therapeutics announced that they are collaborating to develop precision therapies for amyotrophic lateral sclerosis (ALS) and other
July 26, 2021 – The FDA’s Office of Prescription Drug Promotion cited Amgen for making misleading claims that the delivery of its product
Eight dividend-paying pharmaceutical stocks to purchase in pursuit of profits and income feature established industry behemoths and two
The CEO Test In their new book, The CEO Test: Master the Challenges that Make or Break All Leaders Adam Bryant, who has interviewed more than 600
We spent the week taking a closer look at many aspects of a life sciences career, from the companies that are hiring across Ireland to the reasons